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Purpose: To identify strabismus-related proteins, we performed proteome analysis in monozygotic twins with discordance
of congenital esotropic phenotypes and in normal children.
Methods: Surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry (SELDI-TOF-MS) technology
was used to detect changes in protein expression in a pair of twins with discordant esotropic phenotypes (twin A is
orthotropic and twin B is esotropic). In addition, two non-twin esotropic children and two orthotropic children of the same
age were chosen. The differentially expressed proteome obtained was validated in twelve non-twin esotropic children and
eighteen orthotropic children and compared to the protein database.
Results: We detected four differentially expressed proteins in monozygotic twins with discordance of congenital esotropic
phenotypes. The corresponding molecular weights were 4,146 Da, 4,801 Da, 7,786 Da, and 5,859 Da, respectively. Among
these 4 proteins, the first three proteins were down-regulated and the last was upregulated. The initial characterization of
these detected proteins via protein library revealed that their characteristics were similar to those of the glucagon precursor,
pituitary  adenylate  cyclase-activating  polypeptide  (PACAP),  camp-dependent  protein  kinase  inhibitor  α,  and  anti-
metastasis gene (antigen), respectively.
Conclusions: There were differentially expressed proteins between monozygotic twins with discordance of congenital
esotropic phenotypes and normal children. These differentially expressed proteins were mainly down-regulated in the
strabismus patients and may be involved in the occurrence and development of congenital esotropia.
To date, the cause of infantile esotropia is unknown.
Previous studies found that patients with strabismus usually
had positive family history and the incidence of the strabismus
is much higher in monozygotic twins than in multizygotic
twins,  indicating  that  genes  may  play  a  role  in  infantile
esotropia [1-3]. However, it was also found that there were
large individual differences in the strabismus phenotype in
monozygotic  twins  although  DNA  sequences  and  growth
environments are identical in those patients. This indicates
that other factors may also be related to the development of
strabismus. Therefore, it is important to study the related
factors to better understand the etiology of strabismus. In
recent years, the development of proteomics and gene chips
has provided new avenues to study the etiology of strabismus.
In this study, using a technique called surface-enhanced laser
desorption/ionization  time  as  determined  by  time-of-flight
mass spectrometry (SELDI-TOF-MS), we analyzed serum
protein  spectra  and  screened  out  differentially  expressed
proteins in a pair of monozygotic twins with discordance
infantile  esotropia  and  in  children  with/without  infantile
esotropia.
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METHODS
Study  subjects;  selection  of  monozygotic  twins:  The
monozygotic  twins  with  discordance  of  strabismic
phenotypes  was  defined  as  a  pair  of  twins  in  which  one
member had one type of strabismus, while the other was
orthotopic  or  had  a  different  type  of  strabismus  [1].  The
inclusion criteria were as follows: A) twins that were of the
same gender; B) determination by obstetricians at birth; and
C)  similarity  in  phenotype,  as  determined  by
dermatoglyphics, hair color, eye color, nose shape, face shape,
lip  shape,  eyelid  shape,  dentition,  and  other  aspects  of
phenotype. Finally [4], using 10 pairs of fluorescent-labeled
short tandem repeat (STR) primers with a high degree of
heterozygosity in the Chinese population and STR as a gene
marker,  we  performed  genotyping  analysis.  Based  on  the
concordance  of  phenotypes,  we  conducted  zygosity
identification.
Experimental design:
Selection of protein markers—The experimental group
included twin set B and two non-twin congenital esotropia
patients who were similar in age, gender, bodyweight, and
other general characteristics to twin set B. The control group
included twin set A and two healthy children who were similar
in appearance to twin set A but without strabismus, other
related eye diseases, or systemic disease.
Validation of protein markers—Twelve children with
infantile esotropia and eighteen healthy children were chosen
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1618to  validate  the  differentially  expressed  proteins.  This
information revealed that ages and gender were fairly well
distributed among the experimental group and the control
group.
Instruments and reagents: PBSII C-type surface-enhanced
laser desorption/ionization time-of-flight mass spectrometry
(SELDI-TOF-MS) and its software Protein Chip Software3.0,
energy-absorbing molecular CHCA and the H4-type protein
chip were obtained from Ciphergen Ciphergen biosystem Inc.
(Fremont,  CA).  HEPES,  CHAPS,  HPLC-grade  ultra-pure
water and other reagents were from Sigma-Aldrich (St. Louis,
MO).
Collection and pre-processing of serum—We collected
4–5 ml of whole blood from each subject and put the blood
into clean test tubes, then the tubes were immediately placed
at 4 °C for 4 h. The blood samples were then centrifuged at
990× g for 20 min to remove hemolytic specimens, which
were further centrifuged at 1,760× g for 5 min to remove
residual cell debris and to obtain the serum. The serum was
poured into another new 100 μl centrifuge tube and stored at
−80 °C for future use. Before each experiment, the serum
sample was placed on ice to melt, and it was then centrifuged
at 15,860× g for 10 min to remove the insoluble material. Next,
10 μl of serum was taken and mixed with 20 μl U9 buffer (9
mol/l urea, 20 g/l CHAPS, 50 mmol/l Tris-HCI, 10 g/l DTT,
pH 9.0) and shaken in an ice bath for 30 min at 300 r/min. We
then added 360 μl WCX-2 buffer (50 mmol/l NaAc, pH4.0),
and the solution was placed on ice and quickly mixed.
Pretreatment  with  WCX-2  chips—The  chips  were
loaded into a biochip processor and 200μl WCX-2 buffer was
added to each hole. The processor was placed in the oscillator
for 5 min at 300 rpm, and the buffer was then discarded and
the operation repeated once again.
Sample testing—We added 100 μl serum to each hole
and then shook the samples for 1 h at 300 rpm in the oscillator.
Then  samples  were  thrown  off  and  washed  with  200  μl
WCX-2 buffer two times at 300 r/min in the oscillator at room
temperature.  Next,  200μl  HEPES  (1  mmol/l,  pH4.0)  was
added in and immediately shaken off. We opened the chip
processor, took out the chips, dried them, and then added
0.5 μl of sinapinic acid (SPA) onto each point. After drying,
we again added SPA and held for further testing.
TOF data acquisition for serum proteins—A PBSII C-
type mass analyzer and Ciphergen protein chip 3.1 software
were  used  to  read  and  collect  the  data.  Prior  to  the  data
collection, the instrument was calibrated by the All-in-one
standard protein NP20 chip calibration instrument, the error
was kept within 0.1%. The instrument was set to automatically
collect and process the data: the laser intensity was set to 210;
the detection sensitivity was set at 9; the optimized molecular
weight range was 2–10 Da; the highest molecular weight was
50,000 Da. One hundred-thirty collections were performed at
each point and different locations.
Screening of differentially expressed proteins—Twin
set B and two other patients with congenital esotropia were
grouped as the experimental group; twin set A and two other
healthy  children  were  grouped  as  the  control  group.  We
wanted to determine whether the proteins were differentially
expressed between the groups. First, we removed background
noise (baseline) of the protein spectra from the TOF data
acquired from these two groups, and then normalize with the
total ion current and the peak serum protein of 6,638 Da,
which exists stably in human sera, to reduce experimental
error. At last, the Biomarker Wizard software was then used
to calculate the difference of protein peak (p value) among
groups and to identify those differentially expressed proteins.
Validation of differentially expressed proteins—The
screening  of  differentially  expressed  proteins  mentioned
above were verified and analyzed with serum protein spectra
from twelve children with congenital esotropia and eighteen
healthy children using Biomarker Wizard software.
RESULTS
Selection  of  monozygotic  twins:  The  probability  that  the
selected twins will be monozygotic is 99.95%. These twins
were 2-year-old males, born at 32 weeks. The bodyweights at
birth  for  twin  set  A  and  B  were  2,300  g  and  2,200  g,
respectively. The parents reported that twin set B became
esotropic at 1 month old. The twins were normal in refraction
and anterior and posterior segment examination. In twin set
B,  the  left  eye  was  obviously  esotropia,  ocular  motor
examination showed an overaction of the left inferior oblique
muscle. The diagnosis for twin set B was infantile esotropia.
Eye position and eye movement were normal for twin set A.
Their parents were orthotropia and without other eye diseases.
Screening of differentially expressed proteins: We analyzed
the  protein  spectra  from  the  experimental  group  and  the
control group using Biomarker Wizard software and screened
out four differentially expressed protein peaks. Among these,
the molecular weight of the 4,146 Da and 4,801 Da protein
peaks were lower in the sera including twin set B and two non-
twin  infantile  esotropia  patients  as  compared  to  healthy
children (Figure 1A,B); the molecular weight of the 5,859 Da
protein peak was higher in the sera of patients than in the
healthy children (Figure 1C); and the molecular weight of the
7,786 Da protein peak was lower in sera of patients and twin
set A than in the healthy children (Figure 1D).
Verification  of  differentially  expressed  proteins:  The  four
differentially expressed proteins were verified using serum
protein spectra from 30 cases including twelve children with
infantile esotropia and eighteen healthy children. The results
are shown in Table 1.
In Table 1, peak mass is represented as the molecular
weight  of  the  protein  peak.  In  spite  of  there  were  slight
differences in the molecular weight of the same protein peak
in different TOF series, the protein peaks of coming from
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weight  of  protein  were  considered  to  represent  the  same
protein, which the protein peaks from 30 samples was used to
the masses of normalize with Biomarker Wizard software, and
to calculate the average and standard errors for each protein
peak. The term “m/z” denotes the mass-to-charge ratio of the
protein peak. Because of each protein peak carried one charge,
m/z=m, where “m” denotes the molecular weight represented
by the protein peak. “Intensity” means the ratio of intensity/
contents of the protein peak, which derived by subtracting
baseline  values  from  the  protein  peak  S/N  and  then
normalizing by the “total ion” value.
Preliminary prediction of differentially expressed proteins:
We  searched  the  ExPASy  protein  library  (Expert  Protein
Analysis  System)  using  the  initial  features  of  these
differentially expressed proteins, including molecular weights
(MW), isoelectric (pI, according to the pH value of the buffer
used  to  treat  samples),  organism  and  location  (serum)  to
identify database proteins that matched our detected proteins.
We found that proteins of 4,146 Da, 4,801 Da, 5,859 Da, and
7,786  Da  were  similar  to  glucagon  precursor,  pituitary
adenylate cyclase-activating polypeptide precursor (PACAP),
metastasis-suppressor KiSS-1 precursor (Kisspeptin-1) and
cAMP-dependent protein kinase inhibitor alpha, respectively.
Figure 1. Proteins that are differentially expressed between children with and without strabismus. Abscissa is m/z (Da), the axis is the relative
area of the protein peak (S/N). a. monozygotic twins with strabismus; b and c, non-twins with strabismus; d, twins without strabismus; e and
f, two healthy children as controls. Levels of 4,146 Da protein (A) and 4,801 Da protein (B) were lower in children with strabismus (a, b, and
c), as compared to non-strabismus children (d, e, and f); Protein 5,859 Da (C) was highly expressed in strabismus children (a, b, and c), as
compared to non-strabismus children (d, e, and f). Protein 7,786 Da (D) was expressed at lower levels in twins (a and d) and strabismus children
(b and c), as compared to healthy controls (e and f).
TABLE 1. COMPARISON OF FOUR PROTEINS THAT ARE DIFFERENTIALLY EXPRESSED IN THE CONGENITAL ESOTROPIA AND CONTROL
GROUPS (MEANS±S).
Peak mass Experimental group Control group
n M/Z n Intensity n Intensity
30 4146.0±2.28 12 7.29±0.33 18 18.92±0.97a
30 4801.3±1.56 12 7.56±0.84 18 16.89±1.21b
30 5859.4±3.13 12 11.35±2.14 18 5.00±0.78c
30 7786.7±4.32 12 8.84±1.55 18 23.64±1.81d
                Compared with the control group, at’=46.96, p<0.01; bt=23.18, p<0.01; ct’=9.85, p<0.01; dt=23.19, p<0.01.
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Currently, most researchers think that infantile esotropia is a
multi-factorial disease. The scholars who support nerve-factor
theory, which is denoted the “Outgoing Principle,” believe
that  information  on  eye  position  provided  by  the  CNS  is
transmitted to extraocular muscles by efferent nerves. Any
abnormality in this pathway will cause abnormalities of eye
position [5]. Therefore, we sought to determine whether there
was any abnormality in the transmission of signals from the
CNS to the extraocular muscle that was discernible through
the study of proteomics. The proteome comprises all proteins
encoded  by  the  individual’s  genome.  Inter-individual
comparisons of proteomes under normal or disease conditions
may reveal a specific type or group of proteins related to the
disease, provide the best combination of indicators for disease
diagnosis and a theoretical basis and new approach to disease
control  and  prevention,  as  well  as  clarify  the  underlying
mechanism.  By  combining  mass  spectrometry  and
chromatography and other technical principles, SESELDI-
TOFMS allows large-scale testing of original samples such as
sera, urine, etc. This technique can dissociate all types of
proteins for flight mass spectrometry based on flight time in
the field. The information obtained is presented as peaks that
are  intuitive.  With  SESELDI-TOFMS,  one  can  rapidly
acquire proteome-related information. The benefits of this
technique  include  a  high  resolution,  a  high  level  of
reproducibility and ease of operation. The approach is widely
applied in the field of proteome study and has been successful
in identifying specific protein markers in diseases, such as
ovarian, bladder, breast and prostate cancer [6-8].
Because of an individual’s proteome is influenced by the
living  environment,  dining  habits,  age,  gender  and  other
factors, there is great variability in protein expression, so,
proteome studies of common cases must investigate large
sample  to  exclude  the  interference  of  non-specific  causal
factors.  This  greatly  increases  the  cost  of  the  research.
Monozygotic twins have identical genetic backgrounds and
higher-than-average levels of consistency in their proteome.
Therefore, the interference of non-specific proteins to the
study of differential expression proteins is greatly reduced.
Consequently, it is relatively easy to identify disease-specific
proteins  in  monozygotic  twins.  Such  twins  are  the  ideal
subjects  for  proteome  analyses  that  aim  to  identify
differentially  expressed  proteins.  In  tuis  study,  follow-up
surveys  confirmed  that  the  monozygotic  twins  have  been
living in the same environment since birth, further reducing
the  interference  from  non-specific  proteins.  At  first,  we
performed flight mass spectrometry in the set of twins, as well
as a few esotropic children and healthy children that were
matched with the twins studied, and do small sample compare
so as to identify differentially expressed proteins, and then
verify the 4 differentially expressed proteins in a large sample.
This strategy allowed us to exclude the interference from
different genetic backgrounds and living environments. As a
result, we did not need to study two large populations, which
simplified the experiments and reduced costs. Our results will
be important to elucidate the etiology and genetics of this
disease.
The twins in this study were identified as monozygotic
twins.  Twin  set  B  appeared  to  suffer  from  congenital
esotropia, while twin set A appeared to be normal. These twins
have  identical  genetic  backgrounds,  so  the  phenotype
difference between individuals should be caused by acquired,
rather  than  genetic,  factors.  The  molecular  mechanism
underlying  this  phenotype  difference  should  involve
epigenetic  changes.  In  contrast  to  classical  genetic
mechanisms,  which  supply  the  templates  necessary  to
synthesize proteins, epigenetics controls when, where, and
how to use the genetic message.
Throughout  life,  epigenetic  mechanisms  allow
individuals to respond and constant adapt to environment
information [9]. Notably, epigenetic phenomena not only can
be inherited independently but also there are complicated
interrelationships among them. Sometimes disturbances in
epigenetic mechanisms will lead to abnormalities in gene
expression or gene silencing, which can result in dysfunction
or disease. Previous reports on the cause of discordance of
strabismic phenotypes in monozygotic twins also highlight
the  role  played  by  intrauterine  environmental  factors.
Monozygotic  twins  share  one  placenta,  with  vascular
anastomosis between arteries and veins in some placentas. In
such  situations,  blood  circulation  through  the  vascular
anastomosis results in twin transfusion syndrome due to an
imbalanced  placental  vascular  blood  flow.  The  blood
recovered  by  the  umbilical  artery  of  one  twin  enters  the
umbilical artery of the other twin via this anastomosis to
supply nutrients. This blood lacks oxygen, which may lead to
the differences in development that can result in disease in one
twin [10,11]. Thus, differences in the intrauterine blood and
oxygen supply may cause the imbalance of eye development
and  result  in  a  discordance  of  strabismic  phenotypes.
However,  the  molecular  mechanism  underlying  the
phenotype discordance caused by variation in gene expression
and environmental factors remains unknown.
Fraga and coworkers [12] found there were obviously
differences in DNA methylation level and histone site idio-
acetylation between twins by studying discordant phenotypes
of  40  sets  monozygotic  twins.  Our  results  showed  that
esotropic children express lower levels of 4,146 Da, 4,801 Da,
and 7,786 Da proteins but high levels of a 5,859 Da protein.
By searching the protein database, we found that the three
proteins with reduced expression were similar to glucagon
precursor, pituitary adenylate cyclase-activating polypeptide
(PACAP), and cAMP-dependent protein kinase inhibitor α.
The  highly  expressed  protein  was  similar  to  the  anti-
metastasis  gene  (antigen).  Glucagon  precursor  not  only
regulates the absorption of nutrients and the stability of the
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nervous system development by acting as a central nervous
system neurotransmitter [13,14]. Recent research also verified
that the glucagon precursor is involved in visually guided eye
growth regulation [15-17]. If we can confirm that the 4,146
Da protein is indeed the glucagon precursor in our future
research, we will be able to verify that the glucagon precursor
plays  an  important  role  in  the  occurrence  of  congenital
esotropia.  PACAP  is  a  neuropeptide  involved  in  cell
metabolism, cellular differentiation and cell proliferation and
plays important roles in neuron growth and damage repair.
The protein is even regarded as a cerebral protection factor
[18].
However,  until  now,  no  report  has  investigated  the
protein’s relationship to eye neurons and strabismus. We infer
that it may be involved in the occurrence and development of
strabismus by affecting the growth and development of the
nervous system. cAMP-dependent protein kinases act in all
types of tissues as second messengers. Type II exists mainly
in neurons and regulates axonal regeneration after CNS injury.
Under the proper conditions, increased levels of cAMP in
neurons can promote axonal regeneration in the injured CNS
[19-21].  The  proteins  that  we  found  to  have  reduced
expression are all related to the development of nerves and or
muscles.  We  think  these  proteins  probably  be  associated
proteins to development of ocular motor nerves and muscles.
During the nerves and muscles, certain factors render the
intrauterine environment different for each of these twins,
mistakes in the course of gene expression or modification into
biologically active proteins were happened in twin set B.
These  mistakes  resulted  in  an  abnormal  development  of
nerves or muscles related to eye movement, which affected
the CNS pathway responsible for sending out information
regarding eye position to the extraocular muscle, ultimately
resulting in congenital esotropia. Our additional finding that
cAMP-dependent protein kinase expression was also reduced
in twins without strabismus indicates that the expression of
this protein has family or genetic characteristics.
Currently, our group is expanding the number of cases to
further  this  study,  and  we  plan  to  isolate  the  above
differentially expressed proteins and confirm their identity
using  MS-MS  and  other  techniques.  Through  studies  of
proteome  differences,  we  will  be  able  to  identify  protein
markers,  which  can  be  used  in  the  early  diagnosis  of
strabismus and in the analysis of the disease’s causality and
development,  and  to  provide  a  new  way  to  the  study  of
etiology and pathogenesis of strabismus.
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